| Quarter | Score |
|---|---|
| 2013-Q2 | 49.5 |
| 2013-Q3 | 49.1 |
| 2013-Q4 | 49.0 |
| 2014-Q1 | 48.9 |
| 2014-Q2 | 49.2 |
| 2014-Q3 | 49.3 |
| 2018-Q2 | 48.7 |
| 2018-Q3 | 48.9 |
| 2022-Q3 | 65.5 |
| 2022-Q4 | 49.2 |
| 2023-Q1 | 49.1 |
| 2023-Q2 | 36.0 |
| 2023-Q3 | 48.9 |
| 2023-Q4 | 42.5 |
| 2024-Q1 | 48.8 |
| 2024-Q2 | 46.1 |
| 2024-Q3 | 47.1 |
| 2024-Q4 | 45.8 |
| 2025-Q1 | 45.2 |
| 2025-Q2 | 47.8 |
| 2025-Q3 | 47.8 |
| 2025-Q4 | 48.9 |
| 2026-Q1 | 76.5 |
| 2026-Q2 | 72.3 |
Funds reducing exposure or consensus momentum fading
Within 5.5% of funds' estimated purchase price
2 of 16 tracked funds hold GIL. Avg conviction: 8.5%. Net trimming. First tracked at $46.39 (current +5.5% vs tracked).
Oakcliff Capital Partners has 13.1% in this stock
Prices are approximate, based on 13F reported values (position value / shares), not actual cost basis. Data covers 16 tracked value-oriented funds. Holdings are reported quarterly with a ~45-day lag. Stock splits may affect share count comparisons. Returns are not annualized.
| Fund | % of Portfolio | Action |
|---|---|---|
| Oakcliff Capital Partners | 13.1% | Hold |
| Sachem Head Capital | 3.9% | Reduce |